Stay up to date with our newsletter

Get in touch!

To explore career opportunities with Sai Life Sciences, share your CV here.

Lets start the conversation!

Sign up to our newsletter

Thank you!
We will be in touch shortly.

2019.12.03

Krishna Kanumuri, MD & CEO Sai Life Sciences

Global Business Reports interviews Krishna Kanumuri, MD & CEO Sai Life Sciences on the company’s journey of transformation

A recent edition of Global Business Reports (GBR) on India Pharmaceuticals 2019 features the interview with Krishna Kanumuri, MD & CEO of Sai Life Sciences. In the interview, Krishna provides a glimpse of the 20 years of the company, and how it is building itself for the future.

Here’s an excerpt from the interview:
“Sai Life Sciences is undergoing major transformation. Over a period from 2016 to 2020, our company is quadrupling in capacity. This capacity, combined with our proven track record and commitment to building long term partnerships, will no doubt make Sai Life Sciences the partner of choice for large pharma and small biotechs in bringing new medicines to life.”, says CEO Krishna Kanumuri.

Here is the link to read the full interview.

Share article

More News

2025.08.13

Peptide Science & Beyond: Masterclass & Fireside Chat with IISc Professor, Dr. Jayanta Chatterjee

Sai Life Sciences recently hosted Dr. Jayanta Chatterjee, Associate Professor at the Indian Institute of Science (IISc), Bangalore, for two enriching sessions at its campus. The first was the Masterclass Lecture Series, where Dr. Chatterjee addressed a group of scientists at Sai Life Sciences on “Our Adventures in the de novo Design of Helical Macrocyclic […]
Read more

2025.08.13

From vendor to vanguard: Reimagining India’s role in global life sciences

In a recent article published in ET Edge titled, ‘From Vendor to Vanguard: Reimagining India’s Role in Global Life Sciences,’ Krishna Kanumuri, MD & CEO, Sai Life Sciences, highlighted India’s rapidly unfolding transformation from a vendor to an innovation leader in the global life sciences ecosystem.You can read the full article here: From vendor to vanguard: […]
Read more

2025.08.08

Sai Life Sciences Limited Reports Revenue growth of 77% YoY

Q1FY26 Revenue at ₹496 Cr; EBITDA at ₹125 Cr; Net Profit at ₹60 Cr. Hyderabad, August 08, 2025: Sai Life Sciences Limited (BSE: 544306 I NSE: SAILIFE), an innovator focused, Contract Research, Development and Manufacturing Organization (CRDMO) announced its financial results for the first quarter of Fiscal year 2026. Financial Performance: Particulars (₹ crores) Q1FY26 […]
Read more

2025.07.04

ISB professor talk

Exploring climate, water, plastic pollution & related stories: A fireside chat with ISB Prof. Anjal Prakash

To mark World Environment Day, Sai Life Sciences hosted an engaging fireside chat on June 6, 2025, with Dr. Anjal Prakash, Clinical Associate Professor at ISB (Indian School of Business) and lead author on multiple IPCC reports. The session was designed not just to raise awareness but to spark deeper conversations around sustainability, public policy, […]
Read more

2025.06.17

Peptide research center

Sai Life Sciences’ Peptide Research Center gets featured in Lab Design News

Sai Life Sciences’ newly launched Peptide Research Center was featured in Lab Design News, offering insights into the design philosophy and intent behind the facility. The article showcases how the center brings together synthesis, purification, and conjugation under one roof, with a layout optimized for high-throughput workflows and seamless cross-functional collaboration. The feature also spotlighted […]
Read more